Видео ютуба по тегу Trial: Amplify

Coke Zero: Amplify visibility and drive trial with digital sampling promotion on newly launched SKU
Coke Zero: Amplify visibility and drive trial with digital sampling promotion on newly launched SKU
Case Amplify: Purpose-Built AI for Case Work
Case Amplify: Purpose-Built AI for Case Work
Prostate Cancer Clinical Trial: AMPLIFY
Prostate Cancer Clinical Trial: AMPLIFY
AMPLIFY-201: a lymph node-targeted, mKRAS-specific vaccine in pancreatic & colorectal cancer
AMPLIFY-201: a lymph node-targeted, mKRAS-specific vaccine in pancreatic & colorectal cancer
Drs. Susan O’Brien and Catherine Coombs review GAIA/CLL13 and AMPLIFY trials
Drs. Susan O’Brien and Catherine Coombs review GAIA/CLL13 and AMPLIFY trials
The AMPLIFY-201 Trial: A Breakthrough in Pancreatic Cancer?
The AMPLIFY-201 Trial: A Breakthrough in Pancreatic Cancer?
Use Case end to end demo for Amplify Joule's power for your enterprise needs
Use Case end to end demo for Amplify Joule's power for your enterprise needs
Ravi Vij & Dr. Nitin Jain Discuss AMPLIFY: Acalabrutinib + Venetoclax + Obinutuzumab in CLL
Ravi Vij & Dr. Nitin Jain Discuss AMPLIFY: Acalabrutinib + Venetoclax + Obinutuzumab in CLL
Case Amplify Product Demo - Transform Your Casework
Case Amplify Product Demo - Transform Your Casework
Case Amplify - Smarter Casework for Deeper Impact
Case Amplify - Smarter Casework for Deeper Impact
Amplify
Amplify
Get Your FREE Trial: AI Tools to Amplify Your Business | Greg Jameson
Get Your FREE Trial: AI Tools to Amplify Your Business | Greg Jameson
Practice-changing updates in CLL from ASH 2024: findings from the AMPLIFY trial
Practice-changing updates in CLL from ASH 2024: findings from the AMPLIFY trial
Amplify Argument Engagement with a Mock Trial | Spark Creativity Podcast Ep. 361
Amplify Argument Engagement with a Mock Trial | Spark Creativity Podcast Ep. 361
AMPLIFY Trial: Acalabrutinib Plus Venetoclax for CLL
AMPLIFY Trial: Acalabrutinib Plus Venetoclax for CLL
Interim results of AMPLIFY: AV/AVO versus chemoimmunotherapy for first-line treatment of CLL
Interim results of AMPLIFY: AV/AVO versus chemoimmunotherapy for first-line treatment of CLL
ASH 2024 CLL Highlights - SEQUOIA, AMPLIFY, CELESTIAL
ASH 2024 CLL Highlights - SEQUOIA, AMPLIFY, CELESTIAL
Amplify the Site Voice in Clinical Trial Finances
Amplify the Site Voice in Clinical Trial Finances
AMPLIFY: una nuova opzione terapeutica in 1L nella leucemia linfatica cronica
AMPLIFY: una nuova opzione terapeutica in 1L nella leucemia linfatica cronica
CLL highlights from ASH: the Phase III AMPLIFY trial
CLL highlights from ASH: the Phase III AMPLIFY trial
ASH24: Interim Analysis of the Multicenter, Open-Label, Randomized, Phase 3 AMPLIFY
ASH24: Interim Analysis of the Multicenter, Open-Label, Randomized, Phase 3 AMPLIFY
An Amplify case study by Marthinus van der Nest
An Amplify case study by Marthinus van der Nest
The Case for Apologetics | Lee Strobel | Amplify 2023
The Case for Apologetics | Lee Strobel | Amplify 2023
Confundus Charm Card Trial - First Encounter - Confuse and Amplify|Harry Potter Magic Awakened #54.7
Confundus Charm Card Trial - First Encounter - Confuse and Amplify|Harry Potter Magic Awakened #54.7
Amplify and Act: Case-Based Discussions With Heart Failure Experts
Amplify and Act: Case-Based Discussions With Heart Failure Experts